Steinke D T, Seaton R A, Phillips G, MacDonald T M, Davey P G
Medicines Monitoring Unit (MEMO), University of Dundee, UK.
J Antimicrob Chemother. 1999 Jun;43(6):841-3. doi: 10.1093/jac/43.6.841.
Urine samples with trimethoprim-resistant or trimethoprim-sensitive Gram-negative bacteria and samples with no bacterial growth (NG) were identified. Age-sex matched community controls were generated with each trimethoprim-resistant case. These four groups were evaluated for exposure. Prior trimethoprim use was significantly more common in the trimethoprim-resistant group when compared with the trimethoprim-sensitive or the NG group. Prior hospitalization was significantly less common in the trimethoprim-resistant than the trimethoprim-sensitive group, but not with the NG group. Prior oestrogen exposure was associated with trimethoprim resistance. There were no associations found for diabetes or prior corticosteroid exposure. Community controls were found to be inappropriate controls for the study of trimethoprim-resistant bacteria in urine samples.
识别出含有对甲氧苄啶耐药或敏感的革兰氏阴性菌的尿液样本以及无细菌生长(NG)的样本。针对每例对甲氧苄啶耐药的病例,生成年龄和性别匹配的社区对照。对这四组进行暴露评估。与对甲氧苄啶敏感组或NG组相比,对甲氧苄啶耐药组先前使用甲氧苄啶的情况明显更常见。与对甲氧苄啶敏感组相比,对甲氧苄啶耐药组先前住院的情况明显更少,但与NG组相比无差异。先前的雌激素暴露与甲氧苄啶耐药有关。未发现糖尿病或先前使用皮质类固醇与耐药有关。发现社区对照不适用于尿液样本中对甲氧苄啶耐药细菌的研究。